Navigation Links
China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results
Date:11/11/2010

h and profitability, while positioning China Pharma to benefit from China's unprecedented $124 billion healthcare reform program," said Ms. Li.  "We believe our future success will be defined by our high-quality manufacturing facilities, strong distribution relationships, and commercialization expertise."

Pipeline UpdateAs of September 30, 2010, China Pharma had nine pipeline drugs in different stages of registration process, including three that have passed China State Food and Drug Administration ("SFDA") technical analysis and entered clinical trials.

  • The Company has completed clinical trials of Candesartan, a front-line drug therapy for the treatment of hypertension. The Company has completed all testing procedures and currently awaits final SFDA production approval.
  • The Company continues to receive positive feedback from patients in the clinical trial of Rosuvastatin, a generic form of Crestor. The majority of patients in the clinical trial have completed the treatment cycle and the trial is near completion.
  • The Company completed Phase I clinical trials of its novel cephalosporin-based combination antibiotic in the third quarter of 2010.  Phase I of the clinical trials focused on the study of clinical pharmacology as well as the evaluation of safety on the human body, while observing tolerance and pharmacokinetics to provide support for dosage and drug delivery design. Phase II has commenced.

  • Conference CallThe Company will hold a conference call at 8:00 am EST on November 11, 2010 to discuss third quarter 2010 results.  Listeners may access the call by dialing 1-800-659-2056 or 1-617-614-2714 for international callers; access code: 56441223.  A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com.  A replay of the call will be accessible through November 18, 2010 by dialing 1-888-286-8010 or 1-617-80
    '/>"/>

    SOURCE China Pharma Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
    2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
    3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
    4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
    5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
    6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
    7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
    8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
    9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
    10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
    11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... ATLANTA , April 24, 2015 Allowing ... naloxone could reduce drug overdose deaths that involve opioids, ... (CDC) study, "Disparity in Naloxone Administration by Emergency Medical ... Rural Communities," published in the American Journal of ... 16,000 deaths in the United States ...
    (Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, announced the Company ... on Tuesday, April 28, 2015 to discuss the 1st ... to listen to the call by dialing 1-888-346-3479. International ... Participants should ask to be joined into the IGI ...
    (Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
    Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3
    ... 8, 2011 Novation, the leading health care supply ... Medical (St. Paul, MN) to its portfolio of agreements ... Jude Medical is a leading provider of medical devices ... company provides a full portfolio of arrhythmia management products, ...
    ... HOFFMAN ESTATES, Ill., April 8, 2011 Life Spine, ... markets products for the surgical treatment of spine disorders, ... out of nine new products scheduled for launch in ... (AANS) Annual Meeting in Denver, Colorado. ...
    Cached Medicine Technology:Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio 2
    (Date:4/24/2015)... New York, New York (PRWEB) April 24, 2015 ... continue to move forward in the federal ... of South Carolina. According to court documents, the ... Status Report on April 16th detailing, among other ... The report notes that counsel for both plaintiffs ...
    (Date:4/24/2015)... April 24, 2015 The first step ... the mind. , For meditation and yoga teacher Stine ... have been invaluable tools that allow her to experience ... She has been a teacher since 2006, and through ... inner state of being. , “I love sharing this ...
    (Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in ... announced their exclusive agreement with LTC Solutions for All ... distribution partner. , Anchor has more than 18 years ... for associations, and is currently the designated advocate for ... Care Insurance member benefit. , “I am very pleased ...
    (Date:4/24/2015)... “Kind,” “selfless,” “the voice of reason” and ... Weiner described pediatric oncology nurse Laura Vasquez of Children’s ... during her five-year battle with a malignant brain tumor. ... and numerous experimental treatments, Vasquez continued caring for Alexa, ... was not in the hospital and even sitting vigil ...
    (Date:4/24/2015)... 2015 National Access Cannabis ... access to medical cannabis, is taking a leadership role ... advising patients. , NAC is the first to back ... $250,000 grant, NAC will be providing 300 healthcare professionals ... is to help Canadians gain safe and responsible access ...
    Breaking Medicine News(10 mins):Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2
    ... 5 Longs Drug,Stores Corporation (NYSE: LDG ... the fourth quarter ended January 31, 2008, a,14-week ... share, including a,$1.1 million after-tax net gain related ... from continuing operations for the fourth quarter,ended January ...
    ... of assessment,and improvement activities for individual physician practices, ... of,Medical Specialties (ABMS) announced today that Blue Cross ... ABMS Patient Safety Improvement,Program to HMO and PPO ... and safety in patient care. BCBSIL is the ...
    ... March 5 Medifast, Inc.,(NYSE: MED ) announced today ... for the period ended December 31, 2007 on,Wednesday, March 12, ... call and webcast to discuss the results on Thursday, March ... the call by dialing (877) 407-0782 or,(201) 689-8567, or can ...
    ... first, study finds , , WEDNESDAY, March 5 (HealthDay News) -- ... more likely to become pregnant again within two years of ... study. , The study followed 269 predominately black American, low-income ... five community sites. One or two years after giving birth, ...
    ... Cancer Society, the American College of Radiology, and ... (a group that comprises representatives from the American ... Society for Gastrointestinal Endoscopy) have released the first-ever ... guidelines add two new tests to the list ...
    ... when abusive parents with multiple children target just one ... the abused child from the home and return the ... children can suffer lifelong emotional scars from helping parents ... forced to participate in torturing their siblings, according to ...
    Cached Medicine News:Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 14Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 15Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 2Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 3Health News:Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008 2Health News:Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 2Health News:Health groups issue updated colorectal cancer screening guidelines 2Health News:Health groups issue updated colorectal cancer screening guidelines 3Health News:Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: